Advertisement

Topics

Dr. Alan M. Lazar, MD Company Profile

14:14 EST 17th December 2018 | BioPortfolio


News Articles [62 Associated News Articles listed on BioPortfolio]

Alan Rhodes

bmj;362/aug15_16/k3525/FAF1faAlan Rhodes was a skilful surgeon, enabling mentor, and consummate after dinner speaker. After a stellar performance at Wolverhampton grammar school Alan entered...

JLL names Alan Tse general counsel

CHICAGO, June 14, 2018/PRNewswire/ -- JLL (NYSE: JLL) has appointed Alan Tse Global General Counsel and Corporate Secretary effective June 27. A distinguished attorney and leader with Read mo...

Cytogel Pharma, LLC. Announces the appointment of Alan W. Dunton, M.D. to its Board of Managers

DARIEN, Conn., Sept. 7, 2018 /PRNewswire/ -- C. Dean Maglaris, CEO of Cytogel Pharma, announced today that Alan W. Dunton, M.D. has been named to Read more...

Alan Lewis, 2011 President of LESI explains the importance of Intellectual property to world economy

In this episode of PharmaTelevision News Review, Fintan Walton talks to Alan Lewis, 2011 President of LESI

Alan Alda Reveals Parkinson's Diagnosis

TUESDAY, July 31, 2018 -- Alan Alda revealed Tuesday that he's been living with Parkinson's disease for more than three years. "The reason I want to talk about it in public is that I was diagnosed thr...

Welcoming Alan Warren to our 10th Annual Fall Conference!

Health 2.0 is proud to present Alan Warren, the CTO and SVP of Engineering for Oscar Health, who will be joining us for the mainstage panel “The Next Gen Consumer: Technology for Health Choices.” ...

Biosceptre: A New Approach to Cancer Research

In this episode of PharmaTelevision News Review, Fintan Walton talks with Alan Bootes, Chairman of Biosceptre International Ltd. Filmed at AusBiotech 2009, they discuss: • Biosceptre's unconventiona...

Diabetes drugs aid macrophages to control inflammation

Dr Lazar’s team identified that TZDs, while working for PPAR gamma, promoted the metabolism of glutamine, an amino acid... The post Diabetes drugs aid macrophages to control inflammation appeared fi...

Drugs and Medications [0 Results]

None

PubMed Articles [33 Associated PubMed Articles listed on BioPortfolio]

Correction to: The relationship of pelvic incidence to post-operative total hip arthroplasty dislocation in patients with lumbar fusion.

The original publication of this paper contain an error. The author name "Alan S. McGee Jr" is incorrect for it should have been "Alan W. McGee Jr".

Endogenous cycles, activity patterns and energy expenditure of an intertidal fish is modified by artificial light pollution at night (ALAN).

The increase of global light emissions in recent years has highlighted the need for urgent evaluation of their impacts on the behaviour, ecology and physiology of organisms. Numerous species exhibit d...

Personality and artificial light at night in a semi-urban songbird population: No evidence for personality-dependent sampling bias, avoidance or disruptive effects on sleep behaviour.

Light pollution or artificial light at night (ALAN) is an increasing, worldwide challenge that affects many aspects of animal behaviour. Interestingly, the response to ALAN varies widely among individ...

Artificial light at night and captivity induces differential effects on leukocyte profile, body condition, and erythrocyte size of a diurnal toad.

Light pollution or artificial lighting at night (ALAN) is an emerging threat to biodiversity that can disrupt physiological processes and behaviors. Because ALAN stressful effects are little studied i...

Population-level study links short-wavelength nighttime illumination with breast cancer incidence in a major metropolitan area.

Several population-level studies revealed a positive association between breast cancer (BC) incidence and artificial light at night (ALAN) exposure. However, the effect of short-wavelength illuminatio...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Rig

RATIONALE: Recently, the importance of prognosis according to the location of the primary tumor in colorectal cancer has been raised. In the CALGB / SWOG 80405 study published in 2016, the...

Does Illumination From Computer Screen Disrupts Sleep and Biological Rhythms?

Light exposure is on the rise in recent years. In large part because of unintentional illumination from screens that emit light directly into the eyes. Millions of computers, tablets, TVs,...

Mind-body Treatments for Chronic Back Pain

Participants with chronic back pain will complete an online prescreen. They will then be randomized to one of two different studies: a placebo vs. waitlist study or a psychotherapy vs. wai...

Companies [40 Associated Companies listed on BioPortfolio]

Dr. Alan M. Lazar, MD

Alan James Group

Alan James Group, a wholly owned subsidiary of Interleukin Genetics, Inc., is a healthcare-focused consumer products company targeting the growing market for self-medication and preventive healthc...

Lazar Partners Ltd

Lazar Partners recognizes that every client has distinct audiences, advantages, challenges and strengths and these must be reflected in a tailored communications program. Our strategic process to crea...

GeoBiotics, LLC’s

Alan joined GeoBiotics in 2004 as Manager, Africa and was appointed CEO in October 2005. Alan holds a B.Sc. (Eng.) (Hons.) in Mineral Technology from the Royal School of Mines, University of London, ...

Office of Alan R. Stein, D.D.S.

Alan Stein, D.D.S. brings over 35 years of experience to the San Fernando Valley and surrounding areas. He is a member of the American Dental Association, the California Dental As...

More Information about "Dr. Alan M. Lazar, MD" on BioPortfolio

We have published hundreds of Dr. Alan M. Lazar, MD news stories on BioPortfolio along with dozens of Dr. Alan M. Lazar, MD Clinical Trials and PubMed Articles about Dr. Alan M. Lazar, MD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dr. Alan M. Lazar, MD Companies in our database. You can also find out about relevant Dr. Alan M. Lazar, MD Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record